Clinical Responses and Pharmacokinetics of MCARH171, a Human-Derived Bcma Targeted CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma: Final Results of a Phase I Clinical Trial
Work
Year: 2018
Type: article
Source: Blood
Cites:
Cited by: 85
Related to: 10
FWCI: 6.623
Citation percentile (by year/subfield): 88.74
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze